How Does Diabetes Affect the Endocrine System?

Diabetes disrupts the endocrine system far beyond the well-known problem of insulin. Because insulin interacts with virtually every other hormone in the body, its absence or ineffectiveness sets off a cascade of changes in glands and tissues that most people never associate with blood sugar. The stress-hormone axis ramps up, reproductive hormones shift, growth signals misfire, and even bone and fat tissue alter their hormonal output. Understanding these ripple effects helps explain why diabetes causes such a wide range of complications and why managing it involves much more than watching glucose numbers.

Glucagon and the Alpha Cell Problem

Most conversations about diabetes focus on beta cells, the ones that make insulin. But the pancreas also contains alpha cells, which produce glucagon, a hormone that raises blood sugar by telling the liver to release stored glucose. In a healthy pancreas, alpha cells quiet down after a meal when blood sugar is already rising. In diabetes, they do not behave properly. Alpha cells keep pumping out glucagon even when blood sugar is high, a state called hyperglucagonemia. This excess glucagon drives the liver to keep producing glucose the body does not need, pushing blood sugar even higher.

This misbehavior shows up in both type 1 and type 2 diabetes. In type 1, the destruction of beta cells removes an important local signal that normally tells neighboring alpha cells to stand down. In type 2, alpha cells become resistant to the usual suppression signals from insulin and other molecules released nearby. The result is the same: too much glucagon at exactly the wrong times. Some researchers argue that hyperglucagonemia is not just a side effect of diabetes but a primary driver of the high blood sugar that defines the disease.

¹

Between meals and during fasting, hyperglucagonemia contributes to elevated fasting blood sugar through inappropriate liver glucose production. After meals, blunted alpha cell suppression adds to the postprandial spike.

²

The Cortisol Feedback Loop

Cortisol, the body’s primary stress hormone, has a complicated two-way relationship with diabetes. Your brain’s hypothalamus tells the pituitary gland to release ACTH, which then tells the adrenal glands to produce cortisol. This chain of command is known as the HPA axis, and in people with type 2 diabetes it runs hotter than it should. Studies find that people with type 2 diabetes have higher urinary cortisol, reduced ability to suppress cortisol with standard clinical tests, and exaggerated cortisol responses to stimulation, all signs that the HPA axis is clearly overactive.

³

The trouble is that cortisol itself raises blood sugar. It tells the liver to ramp up glucose production through a process called gluconeogenesis. So diabetes drives cortisol up, and cortisol drives blood sugar up, creating a self-reinforcing cycle. Research also shows an independent link between this exaggerated cortisol response and insulin resistance, meaning the cortisol problem is not just a passive consequence of high blood sugar but actively makes the metabolic situation worse.

⁴

What makes this especially relevant to everyday life is that an overactive stress-hormone system is closely linked to depression. People with type 2 diabetes already face higher rates of depression than the general population, and a dysregulated HPA axis appears to be one of the biological bridges connecting the two conditions. Interestingly, HPA axis changes may begin before diabetes is formally diagnosed. Research comparing people with prediabetes to those with established type 2 diabetes found that both groups had significantly higher cortisol levels than healthy controls, and ACTH was elevated even in the prediabetes stage.

⁵

Growth Hormone and IGF-1

Growth hormone and its downstream messenger, IGF-1, are essential for tissue maintenance, muscle health, and metabolism throughout life. Insulin plays a quiet but critical role in this system by controlling how sensitive the liver is to growth hormone. When insulin levels in the portal vein (the blood vessel leading from the gut to the liver) are adequate, the liver expresses plenty of growth hormone receptors and responds by producing IGF-1. When portal insulin is low, as it is in type 1 diabetes and during prolonged fasting, the liver becomes resistant to growth hormone. The result is low IGF-1 despite high circulating growth hormone, a pattern sometimes called “GH resistance.”

⁶

This disruption matters because IGF-1 normally feeds back to the pituitary to keep growth hormone secretion in check. Without that brake, growth hormone levels stay elevated, which itself worsens insulin resistance. In type 1 diabetes specifically, injected insulin enters the bloodstream through the skin rather than traveling directly to the liver as naturally produced insulin does. This means the liver may never see the insulin concentrations it needs to properly activate the growth hormone system, even when blood sugar control seems adequate.

⁷

Thyroid Disruptions During Acute Illness

Diabetes does not typically cause permanent thyroid disease on its own, though people with type 1 diabetes are at higher risk of autoimmune thyroid conditions because of shared genetic susceptibility. What diabetes can do is temporarily scramble thyroid hormone levels during periods of metabolic crisis. A condition known as euthyroid sick syndrome, where thyroid hormone levels drop even though the thyroid gland itself is healthy, is common when diabetes first presents or during severe episodes like diabetic ketoacidosis.

A study of children at the onset of type 1 diabetes found that roughly a third presented with euthyroid sick syndrome, and it was more common in those with more severe metabolic and kidney problems at diagnosis. Importantly, the syndrome resolved on its own once the metabolic crisis was treated, meaning the thyroid gland was never truly damaged. Free T3, one of the active thyroid hormones, correlated inversely with markers of metabolic severity like triglycerides and creatinine.

⁸

Reproductive Hormones

Diabetes affects the reproductive endocrine system in both men and women, though through somewhat different mechanisms. In men with type 2 diabetes, chronically elevated blood sugar and insulin resistance damage Leydig cells, the testicular cells responsible for producing testosterone. The damage occurs partly through downregulation of insulin receptors on these cells, which disrupts the biochemical pathways that synthesize testosterone. Lower testosterone then feeds back to reduce sex drive, energy, and muscle mass, problems that many men with type 2 diabetes experience but may not connect to their blood sugar.

⁹

In women, the connection often runs through insulin resistance and excess insulin. When insulin levels are chronically high, the ovaries are stimulated to produce more androgens (male-type hormones) independently of the normal hormonal signals from the brain. Polycystic ovary syndrome, the most common androgen-excess disorder in women, is closely tied to insulin resistance. This is why treatments that improve insulin sensitivity can also improve menstrual regularity and reduce excess hair growth in women with PCOS, even though those symptoms seem unrelated to blood sugar on the surface.

¹⁰

The Gut’s Hormonal Contribution

Your gut is not just a digestive tube; it is one of the largest hormone-producing organs in the body. When you eat, specialized cells lining the intestine release hormones called incretins, which tell the pancreas to ramp up insulin production in anticipation of incoming sugar. This system is remarkably efficient in healthy people, accounting for a large portion of the insulin released after a meal. In obesity and type 2 diabetes, however, the incretin effect is blunted. The gut cells release fewer incretins, and the beta cells in the pancreas become less responsive to the signals they do receive. This impairment is linked to chronic high blood sugar itself, suggesting that poor glucose control gradually poisons the very system designed to manage it.

¹¹

The gut also shapes the endocrine landscape through its resident bacteria. The microbiome produces short-chain fatty acids from dietary fiber, and these molecules act as signaling agents that influence insulin sensitivity, inflammation, and even appetite-regulating hormones through what researchers describe as the gut-brain axis and a broader neuroendocrine-immune network. In people with type 2 diabetes, the composition of gut bacteria shifts in ways that reduce short-chain fatty acid production, weakening this protective metabolic signaling.

¹²

When Counterregulation Fails

The body has an elaborate emergency system for dealing with low blood sugar. When glucose drops, the adrenal glands release epinephrine (adrenaline), the pancreas releases glucagon, and cortisol and growth hormone rise, all working to push blood sugar back up. People without diabetes rarely need to think about this system because it works automatically. For people with diabetes, especially those on insulin, these defenses can break down in a dangerous way.

In type 1 diabetes, the glucagon response to low blood sugar often disappears within a few years of diagnosis. That leaves epinephrine as the last major line of defense. But repeated episodes of low blood sugar blunt the epinephrine response too, creating what researchers call hypoglycemia-associated autonomic failure. The body stops sounding the alarm when blood sugar falls, which means the person no longer feels the warning symptoms like shaking, sweating, or a racing heart. Without those warnings, severe low blood sugar episodes become more likely, creating a vicious cycle where each episode makes the next one harder to detect.

¹³

At the other extreme, diabetic ketoacidosis represents a state of counterregulatory hormone excess. When insulin is severely deficient, glucagon, catecholamines, cortisol, and growth hormone all surge simultaneously, flooding the liver with signals to produce glucose and ketones. The hormonal storm is both a consequence and an accelerator of the metabolic crisis.

¹⁴

Hormones from Bone, Fat, and Kidneys

Some of the most surprising endocrine effects of diabetes involve organs that people do not think of as hormone producers. Bone, for instance, secretes a hormone called osteocalcin that promotes beta cell growth, stimulates insulin secretion, and improves insulin sensitivity. Osteocalcin also influences fat cells and male reproductive hormone activity. Insulin, in turn, regulates osteocalcin release, creating a feedback loop between the skeleton and the pancreas. When diabetes disrupts insulin signaling, this bone-pancreas conversation degrades, potentially contributing to both metabolic and skeletal problems.

¹⁵

Fat tissue is another major endocrine organ. Adipocytes secrete hormones like adiponectin and leptin that help regulate appetite, insulin sensitivity, and energy balance. In obesity-driven type 2 diabetes, adiponectin levels tend to fall while leptin signaling becomes less effective, undermining the metabolic feedback loops that normally keep blood sugar and body weight in check.

¹⁶

The kidneys also have an underappreciated hormonal role. They produce erythropoietin (EPO), the hormone that signals bone marrow to make red blood cells. In diabetic kidney disease, EPO production fails to increase appropriately when hemoglobin drops, leading to anemia that is often disproportionately early and severe compared to people with non-diabetic kidney disease at a similar stage. Damage to the kidney’s tubulointerstitial tissue and autonomic nerve dysfunction are thought to contribute to this blunted EPO response.

¹⁷

The kidneys also produce a protein called klotho, which helps regulate calcium and phosphate balance, protect blood vessels from calcification, and reduce inflammation. In type 2 diabetes and diabetic kidney disease, klotho expression drops significantly. This decline may both indicate and accelerate kidney damage, and researchers are investigating whether restoring klotho levels could slow the progression of diabetic complications.

¹⁸

The Renin-Angiotensin-Aldosterone System

The kidneys also house the renin-angiotensin-aldosterone system (RAAS), a hormonal cascade best known for regulating blood pressure and fluid balance. In type 2 diabetes, RAAS activity becomes intertwined with metabolic dysfunction. Research has shown that aldosterone levels rise with increasing insulin resistance, independent of blood pressure medications or other RAAS drugs. Meanwhile, renin levels track with hemoglobin A1c and fasting blood sugar in people without hypertension, suggesting the system responds to metabolic signals, not just blood pressure.

¹⁹

This matters because aldosterone itself worsens insulin resistance and promotes inflammation and fibrosis in the kidneys and heart. It is one reason why drugs that block the RAAS, such as ACE inhibitors and angiotensin receptor blockers, are a mainstay of diabetes treatment for kidney and cardiovascular protection, even in patients whose blood pressure is not dramatically elevated.

Melatonin and the Sleep-Glucose Connection

Melatonin, the hormone that signals nighttime and regulates your sleep-wake cycle, also influences insulin secretion. Beta cells in the pancreas have melatonin receptors, and when melatonin binds to them, it dials down insulin release. In people who carry certain genetic variants that cause their beta cells to overexpress the melatonin receptor MTNR1B, the inhibition is exaggerated. This leads to reduced insulin secretion in response to glucose and an increased risk of developing type 2 diabetes.

²⁰

This finding helps explain why shift workers and people with chronically disrupted sleep patterns face higher diabetes risk. When melatonin is present at abnormal times, such as during a late-night meal eaten under conditions of elevated melatonin, insulin release may be suppressed at exactly the moment the body needs it most. It is a reminder that the endocrine system does not operate as isolated switches. Hormones meant for one purpose, like signaling darkness, interact with hormones meant for another, like managing blood sugar, in ways that can amplify disease risk when routines are disrupted.

Pregnancy and Placental Hormones

Pregnancy creates a temporary but powerful endocrine environment of its own, and diabetes alters the conversation between the placenta and the mother’s metabolism. The placenta produces a hormone called placental lactogen that helps redirect nutrients toward the growing fetus, partly by increasing insulin resistance in the mother. In pregnancies affected by diabetes, placental lactogen levels tend to be elevated compared to non-diabetic pregnancies. Disruptions in placental lactogen secretion are associated with complications including abnormalities in fetal growth and placental dysfunction.

²¹

Gestational diabetes itself is sometimes the first sign that a woman’s endocrine system is struggling with insulin resistance, and many of the hormonal disruptions described throughout this article, from cortisol overactivity to impaired incretin signaling, are present in milder forms during pregnancies complicated by gestational diabetes. The placenta’s hormonal output amplifies pre-existing metabolic vulnerabilities, which is why gestational diabetes is a strong predictor of developing type 2 diabetes later in life.

The Heart’s Own Hormone Signal

Even the heart participates in the endocrine web affected by diabetes. The atria of the heart release atrial natriuretic peptide (ANP), a hormone traditionally associated with blood pressure regulation and fluid balance. Research has shown that pancreatic beta cells carry receptors for ANP, and that ANP stimulation increases glucose-stimulated insulin secretion in both mouse and human islets. Perhaps more striking, chronic exposure to ANP appears to protect beta cells against the toxic effects of high glucose and high fat levels, reducing a type of programmed cell death that high blood sugar typically triggers.

²²

People with type 2 diabetes often have lower circulating ANP levels than expected for their degree of heart strain, and this deficit may contribute to both the metabolic and cardiovascular complications of the disease. The discovery that a heart-derived hormone directly supports beta cell survival is a good example of how interconnected the endocrine system really is, and why diabetes, by disrupting one node in the network, sends consequences rippling in directions that are still being mapped.